Presentation is loading. Please wait.

Presentation is loading. Please wait.

Outcomes of polytetrafluoroethylene-covered stent versus bare-metal stent in the primary treatment of severe iliac artery obstructive lesions  Michele.

Similar presentations


Presentation on theme: "Outcomes of polytetrafluoroethylene-covered stent versus bare-metal stent in the primary treatment of severe iliac artery obstructive lesions  Michele."— Presentation transcript:

1 Outcomes of polytetrafluoroethylene-covered stent versus bare-metal stent in the primary treatment of severe iliac artery obstructive lesions  Michele Piazza, MD, Francesco Squizzato, MD, Gaya Spolverato, MD, Luca Milan, MD, Stefano Bonvini, MD, Mirko Menegolo, MD, Franco Grego, MD, Michele Antonello, MD  Journal of Vascular Surgery  Volume 62, Issue 5, Pages e1 (November 2015) DOI: /j.jvs Copyright © 2015 Society for Vascular Surgery Terms and Conditions

2 Fig 1 Overall primary patency for 167 limbs treated with bare-metal stents (BMSs) or covered stents (CSs). Journal of Vascular Surgery  , e1DOI: ( /j.jvs ) Copyright © 2015 Society for Vascular Surgery Terms and Conditions

3 Fig 2 Primary patency for 167 limbs treated with bare-metal stents (BMSs) or covered stents (CSs) stratified by TransAtlantic Inter-Society Consensus (TASC) for the Management of Peripheral Arterial Disease C and D lesions. ∗Standard error >10%. Journal of Vascular Surgery  , e1DOI: ( /j.jvs ) Copyright © 2015 Society for Vascular Surgery Terms and Conditions

4 Fig 3 Primary patency between covered stents (CSs) and bare-metal stents (BMSs) for a subcategory of TransAtlantic Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) D lesions, defined as long lesions involving both the common iliac artery (CIA) and the external iliac artery (EIA). ∗Standard error >10%. Journal of Vascular Surgery  , e1DOI: ( /j.jvs ) Copyright © 2015 Society for Vascular Surgery Terms and Conditions


Download ppt "Outcomes of polytetrafluoroethylene-covered stent versus bare-metal stent in the primary treatment of severe iliac artery obstructive lesions  Michele."

Similar presentations


Ads by Google